可必特联合沐舒坦氧气雾化吸入治疗慢性阻塞性肺疾病的疗效及护理被引量：6

导出

摘要目的探讨可必特联合沐舒坦氧气雾化吸入治疗慢性阻塞性肺疾病(COPD)的疗效及护理。方法将48例COPD患者按随机数字表法分为治疗组和对照组,每组24例。2组均在综合治疗(抗感染、平喘、祛痰)的基础上,采用可必特120μg、沐舒坦15mg雾化吸入,1～2次.d-1,7d为1个疗程。治疗组在雾化治疗时给予细致周到的护理干预。对2组患者的疗效进行比较。结果治疗组总有效率为91.7%,对照组总有效率为54.2%,2组比较差异有统计学意义(P<0.05)。结论在雾化治疗时给予护理干预可提高临床治疗效果。

作者喻小华

机构地区南昌市中西医结合医院呼吸科

出处《实用临床医学（江西）》 CAS 2011年第10期107-108,共2页 Practical Clinical Medicine

关键词可必特沐舒坦氧气雾化吸入慢性阻塞性肺疾病护理

分类号 R563 [医药卫生—呼吸系统] R473.5 [医药卫生—护理学]

引文网络
相关文献

参考文献4

1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量：5089
2梁静云.氧射流雾化吸入治疗老年患者呼吸道疾病的不良反应及护理[J].广西医学,2004,26(7):1054-1054. 被引量：29
3李现东,吴雪雁,贾宗岭.长期应用可必特治疗慢性阻塞性肺疾病的临床观察[J].河南大学学报（医学版）,2006,25(3):49-50. 被引量：7
4朱科明,邓小明.沐舒坦对呼吸系统的保护作用及机制[J].上海医学,2000,23(10):637-639. 被引量：336

二级参考文献14

1翁海霞,刘道侯,戴元荣,夏晓东.长期联合吸入异丙托溴胺与沙丁胺醇的老年慢性阻塞性肺疾病患者对支气管扩张剂的反应性观察[J].中国药物与临床,2005,5(5):360-362.
2[1]Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med, 1998, 92:609-623.
3[2]Teramoto S, Suzuki M, Ohga E, et al. Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or with-out chronic obstructive pulmonary diseases. Pharmacology,1999, 59:135-141.
4[3]Gillissen A, Bartling A, Schoen S, et al. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung, 1997, 175:235-242.
5[4]Park NH, Han ES, Lee CS, et al. The inhibitory effect of ambroxol on respiratory burst, de granulation and cytosolic Ca2+ change in degraded immunoglobulin G-activated neutrophils. Pharmacol Toxicol, 1999, 84: 81-87.
6[5]Pfeifer S, Zissel G, Kienast K, et al. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol. EurJ Med Res, 1997, 2:129-132.
7[6]Stettner S, Ledwozyw A. The effect of Ambroxol on bleomycininduced changes in phospholipid composition of rat lung surfactant. Acta Physiol Hung, 1995, 83:181-187.
8[7]Mira E, Benazzo M, De Paoli F, et al. Surfactants of the air-ways. Critical review and personal research. Acta Otorhinolaryngol Ital, 1997, 17(1 Suppl 56):3-16.
9[8]Nemcekova E, Nosalova G, Franova S. Ambroxol and protective reflexes of the respiratory tract. Bratisl Lek Listy, 1998, 99:111-115.
10[9]Tyrakowski T, Greczko Ⅰ, Sedlaczek A, et al. Electrophysiological investigation of the effects of ambroxol on the transepithelial Na + ion transport pathway in airways. Pol J Pharmacol,1998, 50:31-38.